「mac」の検索結果
52件：46～50件目を表示
もしかして
-
General Announcement: May 9, 2024 Senju Pharmaceutical Co., Ltd. Senju announces initiation of Phase III Clinical Trials in Japan for “SJP-0008” for the treatment of Central Retinal Artery Occlusion S...
https://www.senju.co.jp/system/files/content_news/2024-05/ENG_20240509.pdf -
General Announcement: May 9, 2024 Senju Pharmaceutical Co., Ltd. Senju announces initiation of Phase III Clinical Trials in Japan for “SJP-0008” for the treatment of Central Retinal Artery Occlusion S...
https://www.senju.co.jp/system/files/content_news/2024-05/ENG_20240509_0.pdf -
Overseas Activities | SENJU Pharmaceutical
Eye health and pharmaceutical development have no borders. We engage in international activities with a view to the future of pharmaceuticals, transcending national and corporate boundaries. As we ent...
http://www.senju.co.jp/english/global/ -
内注 射液20mg/mL」に関する販売パートナーシップ契約を締結しましたのでお知らせします。 アイザベイTMはアステラス製薬が日本において萎縮型加齢黄斑変性（Atrophic Age-related Macular Degeneration：萎縮型AMD）における地図状萎縮（Geographic Atrophy：GA）の進 行抑制を効能・効果として発売したファーストインクラスの治療薬です。 GAは...
https://www.senju.co.jp/system/files/content_news/2025-11/JPN_20251127.pdf -
Product Development Policy | Research & Development | SENJU Pharmaceutica
essary treatment. In addition, cataracts, refractive errors (myopia, presbyopia, etc.), age-related macular degeneration, glaucoma, and diabetic retinopathy have been reported to be the major causes o...
http://www.senju.co.jp/english/rd/policy/